Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

TerminatedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

November 16, 2019

Study Completion Date

November 16, 2019

Conditions
Colorectal Cancer
Interventions
OTHER

Cologuard

Observational

Trial Locations (20)

21075

Centennial Medical Group, Elkridge

27599

University of North Carolina, Chapel Hill, Chapel Hill

30308

The Kaufmann Clinic, Atlanta

33030

Homestead Medical Research, Homestead

33458

Health Awareness Inc., Jupiter, Jupiter

33756

Innovative Research of West Florida, Clearwater

34984

Health Awareness Inc., Port St. Lucie, Port Saint Lucie

44647

Family Practice Center of Wooster, Massillon

46202

Indiana University, Eskanazi Hospital, Regenstrief Health Center, Indianapolis

55905

Mayo Clinic, Rochester

77356

PCP for Life, Montgomery

78759

Austin Regional Clinic, Austin

84107

Wasatch Clinical Research, Salt Lake City

85206

Central Arizona Medical Associates, PC, Mesa

Fiel Family and Sports Medicine, PC, Tempe

85308

Thomas C Lenzmeier, M.D., P.C., Glendale

89074

Nevada Family Care, Henderson

92008

Cassidy Medical Group, Carlsbad

92262

Desert Oasis Healthcare Medical Group, Palm Springs

92663

John D. Homan, MD, Newport Beach

Sponsors
All Listed Sponsors
lead

Exact Sciences Corporation

INDUSTRY

NCT03705013 - Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01) | Biotech Hunter | Biotech Hunter